ICD-10-CM Billable Code

T52.0

Toxic effects of petroleum products

Clinical Classification Guidelines

Inclusion Terms

  • Toxic effects of gasoline [petrol]
  • Toxic effects of kerosene [paraffin oil]
  • Toxic effects of paraffin wax
  • Toxic effects of ether petroleum
  • Toxic effects of naphtha petroleum
  • Toxic effects of spirit petroleum

Medical Intelligence & Overview

ICD-10 code T52.0 pertains to the toxic effects resulting from exposure to various petroleum products. These substances include gasoline, kerosene, paraffin wax, ether petroleum, naphtha, and spirit petroleum. Exposure can occur through ingestion, inhalation, or skin contact, leading to a range of health issues. Understanding the causes, symptoms, and general approach to diagnosis can help in recognizing and managing these toxic effects, although this information should not replace professional medical advice.

Causes & Symptoms

Clinical Causes: Accidental ingestion of gasoline or kerosene, especially in children Inhalation of vapors from petroleum products during work or improper storage Skin contact during handling or accidents involving petroleum-based substances Intentional intake in cases of poisoning or substance abuse Environmental exposure during spills or leaks

Key Symptoms: Respiratory irritation, including coughing and difficulty breathing Nausea and vomiting Abdominal pain and discomfort Dizziness, headache, and lightheadedness Altered mental status or confusion Skin redness, blistering, or burns upon contact Coughing or wheezing if inhaled vapors are irritating to the respiratory tract Signs of systemic toxicity such as depression of the central nervous system

Diagnostic & Treatment

Diagnosis Path: Diagnosis of petroleum product toxicity is primarily based on history of exposure and clinical evaluation. Healthcare providers often inquire about recent incidents involving ingestion, inhalation, or skin contact. Laboratory tests, though not specific, can help assess the extent of systemic toxicity. Blood tests may reveal elevated levels of hydrocarbons or related substances. Imaging studies are rarely necessary unless aspiration pneumonitis or other complications are suspected.

Treatment Protocols: Treatment focuses on removing the individual from exposure and supportive care. Immediate steps include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T52.0 a billable ICD-10 code?
Yes, T52.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T52.0?
Clinical documentation must specify the nature of Toxic effects of petroleum products and any associated comorbidities for accurate reporting.

Cite this Clinical Reference